We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App




Diagnostic Assay and Handheld Analyzers Exhibited in Dubai

By LabMedica International staff writers
Posted on 28 Jan 2015
A global diagnostics company exhibited its new early sepsis assay and point-of-care hemoglobin analyzer, and previewed its new lactate analyzer at Arab Health 2015.

EKF Diagnostics (Cardiff, UK) exhibited at Arab Health 2015 (January 26-29, Dubai, UAE) to highlight its new DiaSpect Tm handheld hemoglobin analyzer and new CE-marked Liquicolor Procalcitonin liquid-stable assay for early sepsis detection. More...
EKF also previewed SensPoint, a new handheld lactate analyzer with built-in connectivity functions to hospital or laboratory information systems.

DiaSpect Tm is a robust, heat and humidity compatible analyzer delivering immediate hemoglobin results at point-of-care (POC). The lightweight, palm-sized analyzer is reliable for anemia diagnosis in almost all climatic conditions. DiaSpect Tm combines laboratory-quality performance with unmatched measurement speed. Its extensive battery life of 40 days of continuous use, or 10,000 tests, enables long-term use outside of laboratories and in remote resource-poor locations.

DiaSpect Tm is proving highly effective in challenging POC testing (POCT) conditions in many locations, including east Africa and south-east Asia, where heat and humidity can affect performance of devices and blood collection cuvettes. DiaSpect Tm is unaffected by these environmental factors due to its reagent-free disposable cuvettes, and the fact that it has no moving parts.

The plexiglass micro-cuvettes used by DiaSpect Tm have a shelf life of 2.5 years when stored between 0–50 °C, so refrigeration is not necessary. Short-term storage is possible at -3–70 °C for a maximum of 24 hours. Also making it ideal for POCT is that DiaSpect Tm is factory calibrated against the HiCN reference method in accordance with ICSH and requires no recalibration or maintenance, as it undertakes an automatic self-check between every measurement.

DiaSpect Tm is easy to use and requires minimal training as the user simply collects a capillary or venous blood sample of <10 µL into the microcuvette and inserts it directly into the analyzer. Hemoglobin results are delivered in 1 second, and can be downloaded to a computer (via USB or Bluetooth).

The new CE-marked Liquicolor Procalcitonin liquid-stable immunoturbidimetric assay provides early and specific indication of sepsis and can be used on most automatic chemistry analyzers. Since Procalcitonin (PCT) levels elevate during systemic bacterial infection and sepsis, a PCT test can quickly assess initial sepsis severity. Liquicolor PCT is precise, convenient, and cost effective. It can remain stable on-board the analyzer for up to 4 weeks, and requires a minimal sample of just 20 µL. This assay can be run on a primary chemistry analyzer and eliminate the need for sample splitting, thus improving laboratory workflow.

Liquicolor Procalcitonin assay is currently unavailable for sale in USA, France, Germany, Austria, Spain, Italy, and Japan.

Related Links:

EKF Diagnostics



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA
New
Unstirred Waterbath
HumAqua 5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.